Michael Gejl

1.5k citations
25 papers · 1.2k · 1 hit paper · h-index 16

Impact in

Papers in

    • Diabetes Treatment and Management 13
    • Diabetes Management and Research 7
    • Diabetes, Cardiovascular Risks, and Lipoproteins 4
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
    • Diet and metabolism studies 8
    • Alzheimer's disease research and treatments 3

Michael Gejl

25 papers receiving 1.2k citations

Michael Gejl's Hit Papers

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial 2016 · 346 citations
3460+3+6Years since publication100200300

Peers

Michael Gejl
Comparison fields: 5 of 79
  • Endocrinology, Diabetes and Metabolism 563
  • Neurology 169
  • Physiology 457
  • Biological Psychiatry 33
  • Cellular and Molecular Neuroscience 181
Replace Lærke Egefjord with:
Lærke Egefjord Denmark
Kim Vang Denmark
Antonietta Fava Italy
Delin Ma China
Benjamin M. Terry United States
Harumi Kan‐no Japan
Juan Antonio García-Arnés Spain
Anna C. Schacht Denmark
Massimiliano Plastino Italy
Scott Nugent Canada
Michael Gejl relative to Lærke Egefjord Denmark Lærke Egefjord's profile →
Citations per field
00.5×1.6×
Lærke Egefjord · 1×
Citations per year

Countries citing papers authored by Michael Gejl

Since Specialization
Citations

This map shows the geographic impact of Michael Gejl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gejl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gejl more than expected).

Fields of papers citing papers by Michael Gejl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gejl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gejl. The network helps show where Michael Gejl may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Gejl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Gejl Line = papers co-authored together Michael Gejl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Hit paper breakdown →
2016346
2 2017124
3 201486
4 201781
5 201874
6
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.
201270
7 201266
8 201241
9 201132
10 201628
11 201927
12 201327
13 201426
14 201423
15 201622
16 201422
17 201715
18 202215
19 201814
20 201411

About Michael Gejl

Michael Gejl is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (13 papers), Diet and metabolism studies (8 papers), Diabetes Management and Research (7 papers), Pancreatic function and diabetes (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (563 citations), Neurology (169 citations), Physiology (457 citations), Biological Psychiatry (33 citations) and Cellular and Molecular Neuroscience (181 citations). Michael Gejl has collaborated with scholars based in Denmark, Canada and United States. Frequent co-authors include Birgitte Brock, Jørgen Rungby, Albert Gjedde, Lærke Egefjord, Kim Vang, Niels Møller, Arne Møller, Hanne Gottrup, Hans Brændgaard and Anders Rodell. Their work appears in journals such as Diabetologia, Alzheimer s & Dementia, The Journal of Clinical Endocrinology & Metabolism, Journal of Cerebral Blood Flow & Metabolism and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact